跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Omepracent 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Omepracent 40
Approved
STANDARD
Omepracent 40
Windlas Biotech Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ae042a078cd650d3
Company
Windlas Biotech Limited
Type
Standard
Approval Details
Approval Id
ae042a078cd650d3
Drug Approval Philippines Name
Omepracent 40
Product Name
Omepracent 40
Registration Number
DRP-3016-03
Brand Name
Omepracent 40
Generic Name
Omeprazole
Dosage Form
Capsule
Dosage Strength
40 mg
Manufacturer
Windlas Biotech Limited
Importer
Grovic Pharma Inc.
Distributor
Central West Medicale Inc.
Company Detail Path
/organization/windlas-biotech-limited
Issuance Date
11 July 2024
Expiry Date
02 June 2028
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ae042a078cd650d3
Type
Standard
Back to Philippines FDA Approvals